The Prescription Drug Pricing Reduction Act (PDPRA) is expected to work its way through Congress this fall.
Heartland Institute News
David Gortler, a professor of pharmacology and a former FDA official, says the FDA needs to do more to ensure the quality of drugs delivered to the U.S. market, with particular concern given to generic drugs produced in “sweatshop” countries.
'Right to try' patients should not be charged for treatment, health-care policy adviser speaking as 'health care consumer' says
Terminally and chronically ill patients should not be charged for “right to try” treatments, a health-care policy adviser for an Illinois-based free-market think tank, speaking as “a health-care consumer,” said during a recent interview.